What are the opening hours?

Monday 10am - 5am Tuesday 10am - 5am Thursday 10am - 5am Friday 10am - 5am

MitoGENE Technologies

Home
India
Chennai
MitoGENE Technologies

Global medicine supplier | FDA/EMA-approved therapies via Named Patient Program | Generics & APIs for advanced treatments worldwide.

13/04/2026

Access TALVEY® in India with MitoGENE—guided, compliant, and end-to-end support from prescription to treatment under CDSCO pathways.

Learn more:
https://mitogene.org/talvey-talquetamab-access-for-relapsed-refractory-multiple-myeloma-in-india/

09/04/2026

Accessing advanced therapies can be complex for patients and families.

A structured, compliant approach helps ensure safety, clarity, and timely support throughout the process.

Learn more about how access is streamlined:

👉 https://mitogene.org/talvey-talquetamab-access-for-relapsed-refractory-multiple-myeloma-in-india/

07/04/2026

When treatment options are less, don’t worry.
MitoGENE helps you access TALVEY® in India.

👉 https://mitogene.org/talvey-talquetamab-access-for-relapsed-refractory-multiple-myeloma-in-india/

31/03/2026

Accessing FRUZAQLA® in India made simple and compliant.

From doctor recommendation to hospital delivery, every step is handled with care and transparency by MitoGENE through Named Patient Program.

Learn more: https://mitogene.org/fruzaqla-fruquintinib-for-metastatic-colorectal-cancer-via-npp/

27/03/2026

Worried about access to FRUZAQLA®?

We make it simple, legal, and guided.

To know more:

https://mitogene.org/fruzaqla-fruquintinib-for-metastatic-colorectal-cancer-via-npp/

25/03/2026

When treatment options become limited, access shouldn’t be.
FRUZAQLA® offers a new pathway for patients with metastatic colorectal cancer through a compliant Named Patient Program in India.

👉 Learn how access was made possible:
https://mitogene.org/fruzaqla-fruquintinib-for-metastatic-colorectal-cancer-via-npp/

23/03/2026

Access QINLOCK® in India with a simple, guided process under medical supervision. MitoGENE manages every step safely and compliantly.

Learn more: https://mitogene.org/2927-2/

21/03/2026

Eid Mubarak 🌙
Wishing you peace, happiness, and good health today and always.

20/03/2026

Access to life-saving treatment shouldn’t be delayed.
With MitoGENE’s support, patients receive timely access to global therapies, ensuring continuity of care and better outcomes.

👉 Learn how we make treatment accessible:
https://t.co/kZwejBhHeS

18/03/2026

When standard GIST treatments stop working, QINLOCK may be recommended.

But access in India isn’t always straightforward.

MitoGENE helps patients navigate a legal, doctor-guided pathway to access treatment.

👉 Learn more: https://mitogene.org/2927-2/

16/03/2026

Step-by-step access to advanced gastric cancer treatment in India.

See how the Named Patient Program works 👇
https://mitogene.org/accessing-vyloy-zolbetuximab-for-advanced-gastric-cancer-in-india-via-named-patient-program/

13/03/2026

Some globally approved gastric cancer treatments may not yet be widely available in India. Patient-specific access pathways help eligible patients receive these therapies with proper regulatory support.

Learn more:

https://mitogene.org/accessing-vyloy-zolbetuximab-for-advanced-gastric-cancer-in-india-via-named-patient-program/

Address

No:7, Plot:47/1, Selvaraj Nagar, Extn – 2, Urapakkam West
Chennai
603211

Opening Hours

Monday	10am - 5am
Tuesday	10am - 5am
Thursday	10am - 5am
Friday	10am - 5am

Website

http://mitogene.org/

Alerts

Be the first to know and let us send you an email when MitoGENE Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Chennai?